Profil
Dr. Malgorzata Kluba is a Senior Biotechnology Analyst at Candriam Belgium SA.
Before joining Candriam Malgorzata spent 4 years as an R&D scientist at ActoBio Therapeutics (Intrexon Actobiotics) in Belgium – a synthetic biology company where she had been working on novel drug delivery platform.
Before that she worked as a journalist for a life sciences communication agency (BioVox / Tunstone Communications) focusing on Belgian biotechnology market.
She holds PhD degree in biochemistry and biotechnology from University of Leuven, Belgium.
Aktive Positionen von Malgorzata Kluba
| Unternehmen | Position | Beginn |
|---|---|---|
Candriam Belgium SA
 Candriam Belgium SA Investment ManagersFinance Candriam Belgium SA (Candriam) is the Belgian asset management subsidiary of Candriam Luxembourg SCA, ultimately held by New York Life Insurance Co. in the US. Founded in 1998, the firm was formerly known as Dexia Asset Management Belgium SA, the asset management division of Dexia SA (XB: DEXB). In 2014, New York Life Investments acquired Dexia Asset Management and the firm changed their name to Candriam, which is an acronym of their core values: “Conviction and Responsibility in Asset Management”. Headquartered in Brussels, Candriam provides discretionary and non-discretionary investment advisory services to US registered funds, a limited number of US natural persons, and to institutions. | Analyst-Equity | 01.01.2019 |
Ausbildung von Malgorzata Kluba
| Leuven University College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Candriam Belgium SA
Candriam Belgium SA Investment ManagersFinance Candriam Belgium SA (Candriam) is the Belgian asset management subsidiary of Candriam Luxembourg SCA, ultimately held by New York Life Insurance Co. in the US. Founded in 1998, the firm was formerly known as Dexia Asset Management Belgium SA, the asset management division of Dexia SA (XB: DEXB). In 2014, New York Life Investments acquired Dexia Asset Management and the firm changed their name to Candriam, which is an acronym of their core values: “Conviction and Responsibility in Asset Management”. Headquartered in Brussels, Candriam provides discretionary and non-discretionary investment advisory services to US registered funds, a limited number of US natural persons, and to institutions. | Finance |
